PacificHealth Laboratories, Inc.
PHLIOTCConsumer Defensive
$0.00
+$0.00(+9900.00%)
Market Cap$438307
P/E Ratio—
52W High$0.0001
52W Low$0.000001
PacificHealth Laboratories, Inc. (PHLI) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · PHLI · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2011-12 | 2010-12 | 2009-12 | 2008-12 | 2007-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $6.91M | $7.20M | $8.00M | $7.24M | $7.43M |
| Cost of Revenue | $3.93M | $4.04M | $4.77M | $4.21M | $4.89M |
| Gross Profit | $2.99M | $3.16M | $3.22M | $3.02M | $2.54M |
| Gross Margin %(computed) | 43.20% | 43.93% | 40.29% | 41.80% | 34.23% |
| Operating Expenses | |||||
| R&D Expenses | $0.05M | $0.00M | $0.00M | $0.15M | $0.21M |
| G&A Expenses | $2.16M | $2.75M | $3.20M | $3.54M | $0.00M |
| Total Operating Expenses | $3.46M | $3.92M | $5.08M | $4.59M | $3.90M |
| Operating Income | ($0.47M) | ($0.76M) | ($1.94M) | ($2.04M) | ($1.36M) |
| Operating Margin %(computed) | -6.86% | -10.56% | -24.27% | -28.19% | -18.32% |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.05M | $0.07M |
| Interest Expense | $0.01M | $0.01M | $0.01M | $0.00M | $0.00M |
| Income Before Tax | ($0.49M) | ($0.76M) | ($1.94M) | ($1.99M) | ($1.28M) |
| Income Tax Expense | $0.00M | $0.01M | ($0.26M) | $0.00M | $0.00M |
| Net Income | ($0.49M) | ($0.76M) | ($1.68M) | ($1.99M) | ($1.28M) |
| Net Margin %(computed) | -7.03% | -10.57% | -20.96% | -27.56% | -17.18% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.02 | $-0.05 | $-0.11 | $-0.15 | $-0.10 |
| Wtd Avg Shares | 19.55M | 16.15M | 14.97M | 13.66M | 13.31M |
| EBITDA | ($0.43M) | ($0.66M) | ($1.73M) | ($1.83M) | ($1.26M) |
| EBITDA Margin %(computed) | -6.22% | -9.11% | -21.70% | -25.33% | -17.02% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · M
Explore more PacificHealth Laboratories, Inc. data
About PacificHealth Laboratories, Inc. (PHLI) Income Statement
PacificHealth Laboratories, Inc. (PHLI) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2011, PHLI reported revenue of $0.01B, gross profit of $0.00B (gross margin 43.20%), and net income of ($0.00B) — a net profit margin of -7.03%.
Frequently asked questions
PHLI · 4 questionsPacificHealth Laboratories, Inc. (PHLI) reported revenue of $0.01B for 2011, down 4.0% year-over-year.
PHLI revenuePHLI salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08